Stem Cell Therapy Market to Surpass US$ 40.3 Billion by 2027

Stem cells are derived from the human cells. Stem cell therapy is also known as regenerative medicine. Regenerative medicine refers to a group of biomedical approaches (such as tissue engineering), which involves adoption of stem cells. These therapies have the ability to regenerate human cells, tissues, or organs, in order to restore normal functioning of the body. Stem cell therapies are used in the treatment of spinal cord injury, Parkinson’s disease, sickle cell disease, diabetes, and heart diseases.

Read report Overview @ https://www.coherentmarketinsights.com/market-insight/stem-cell-therapy-market-2848

Increasing research and development activities by the market players are one of the major factors that are expected to drive growth of the stem cell therapy market over the forecast period. For instance, in July 2018, the Emory Orthopaedics & Spine Center, in collaboration with Sanford Health, Duke University, Andrews Institute, and Georgia Institute of Technology, received US$ 13 million grant from the Marcus Foundation for a multicenter clinical trial studying stem cell options for treating osteoarthritis. The Phase 3 trial was initiated in March 2019, and is expected to complete by December 2021. Moreover, in December 2017, Mayo Clinic initiated the clinical phase I study on safety and feasibility of mesenchymal stem cell therapy in patients with intracerebral hemorrhage. This therapy is used for treating acute spontaneous hemorrhagic stroke. The study is expected to complete by December 2020.

Moreover, increasing product launches by key players is expected to boost demand for stem cell therapy over the forecast period. For instance, in August 2017, LifeCell, a healthcare service provider, launched an advanced umbilical cord-stem cell collection kit which offers enhanced protection to neonatal stem cells from environmental damage and temperature fluctuations.

Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2848

The global stem cell therapy market is expected to exhibit a CAGR of 21.1% over the forecast period, owing to increasing adoption of collaboration and acquisition strategies by market players and rising adoption of stem cell therapy in the market. For instance, in 2016, Axiogenesis AG and Metrion Biosciences Ltd. entered into a collaboration to validate, optimize, and commercialize induced pluripotent stem cell-derived cells and tissues, to speed up research in drug discovery

Among cell source, adult stem cells segment held dominant position in the stem cell therapy market in 2018, owing to adoption of inorganic growth strategies such as partnerships and collaborations by the market players. For instance, in October 2016, Pall Corporation and RoosterBio Inc., an adult stem cell technology company, announced a co-development and marketing partnership. Under this partnership, the companies offered solutions for expansion of large-scale bioreactors of human mesenchymal stem/stromal cells (hMSCs) to accelerate product development and commercialization of stem cell based therapies in the market.

Among region, North America segment held dominant position in the stem cell therapy market in 2018, owing to rising prevalence of cancer in the region that is expected to drive growth of the stem cell therapy market. For instance, according to a report by National Cancer Institute, in 2016, around 1,685,210 new cases of cancer were diagnosed in the U.S. alone.

Key players operating in the global stem cell therapy market include Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.

Free Sample Report + All Related Graphs & Charts @ https://www.coherentmarketinsights.com/insight/request-sample/2848 

Detailed Segmentation:

Global Stem Cell Therapy Market, By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
Global Stem Cell Therapy Market, By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.